Backed by research

In 2002, Dr. Jong-Moon Jeong—the scientist behind Bomme—founded his research facility in South Korea with this belief: “All diseases come from nature, and all remedies also come from nature.”

Over the next 2+ decades, Dr. Jeong and his team investigated the causes of hair loss and developed a solution using high-quality plant extracts.

Today, Bomme is backed by published clinical trials that demonstrate its safety and efficacy in supporting hair health and promoting optimal conditions for hair wellness.

CLINICAL TRIAL RESULTS

Root Renewal Supplements were shown to support thicker, denser hair in as little as 8 weeks

The 24-week human clinical study was published in Skin Research & Technology, the official journal of the International Society for Bioengineering of the Skin (ISBS). Compared to the control group, Bomme hair growth supplement showed significantly increased hair density and thickness at 8, 16, and 24 weeks in both male and female participants between the ages of 19 and 60.

CLINICAL TRIAL RESULTS

Revitalizing Scalp Toner was shown to improve hair density and thickness in as little as 4 weeks

In a clinical study of the toner conducted by the P&K Skin Research Center in South Korea in 2023, participants saw significantly improved hair density and thickness (up to 72%) after consistently using the toner for 4 weeks.

Drug-free approach

No harsh chemicals or additives like finasteride or minoxidil

Chemicals like finasteride and minoxidil are commonly used for hair loss but may come with side effects for some users. Finasteride has been associated with reduced sexual desire, while minoxidil, a vasodilator, can sometimes cause irritation, such as acne, burning, and inflammation. Bomme, however, offers a natural alternative to support hair health without relying on drugs or harsh chemicals.

OUR INGREDIENTS

Real people are seeing real results

Drag the slider to see hair growth results with Bomme

Patents pending United States 18/280,178 | China 202280017781.8 | Japan 2023-555471

European Union 22788282.6 | India 202317059954 | Singapore 11202308093P